Skip to content

NeoGenomics NEO Earnings yield

Earnings yield at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
4.3%+0.5pp
Quest Diagnostics logo
Quest DiagnosticsDGX
4.8%0.0pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-14.3%-4.6pp
Guardant Health logo
Guardant HealthGH
-3.6%-1.3pp
Natera, Inc. logo
Natera, Inc.NTRA
-1.4%0.0pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-3.7%-1.3pp

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B-21.0%
Enterprise value$1.6B-5.6%
P/S2.3×-0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

Based on trailing twelve months.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's earnings yield?
NeoGenomics (NEO) reported earnings yield of -10.3% in Q1 2026.
How has NeoGenomics's earnings yield changed year-over-year?
NeoGenomics's earnings yield decreased by 61.8% year-over-year, from -6.4% to -10.3%.
What is the long-term trend for NeoGenomics's earnings yield?
Over 5 years (2020 to 2025), NeoGenomics's earnings yield has grown at a 154.3% compound annual growth rate (CAGR), from 0.1% to -7.1%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.